Have you or a loved one been diagnosed with Alzheimer’s disease? If so, you may be eligible to join the RethinkALZ study.

RethinkALZ is a clinical study to advance Alzheimer’s treatment and pave the way to Alzheimer’s-free future generations. Through RethinkALZ clinical research study, we can move one step closer to an Alzheimer’s free population through effective Alzheimer’s medication.

There is no fee to join, you don’t need insurance, and there is a compensation of $125 for every visit, and if you are a study partner, you get $85 for every visit. There are a total of 8 visits.

What’s the purpose of the study?

RethinkALZ is a new clinical trial for Alzheimer’s disease. The purpose of the RethinkALZ trial is to determine if a new, twice-a-day, oral drug candidate called Simufilam is safe and effective in slowing down the progression of mild-to-moderate Alzheimer’s disease.
Simufilam is an investigational drug candidate that has not yet been approved by the United States Food and Drug Administration (FDA) or any regulatory agency to treat any condition. The study will enable researchers to determine the effectiveness of Simufilam and push for its approval.

Eligibility to participate in RethinkALZ

If you or a loved one has been diagnosed with Alzheimer’s disease, or a physician suspects it may be Alzheimer’s disease, you could be eligible to participate in the Alzheimer’s Clinical research study at no cost to you.
To be considered for the RethinkALZ study, patients must:

V

Be ages 50 to 87 years old

V

Have a gradual change in memory for six months or more

V

Have a family member or loved one who can be available as a study partner during the entire study

V

Other criteria will apply

V

Be diagnosed with or have a suspected clinical diagnosis of Alzheimer’s disease

V

Be fully vaccinated for covid-19 or have had a previous COVID-19 infection

Please call us on 844-331-7300 or fill out the form to get started

Find out it you qualify

You can play a role in making this world a better place. Without you, new possible treatments would never be made available you or anyone else.

  • This field is for validation purposes and should be left unchanged.

What RethinkALZ Alzheimer’s clinical study will involve;

V

Questions on your symptoms, health, and lifestyle

V

Labs collected throughout and your health progress supervised by physicians

V

Medication and drugs for free to you

V

You will not need insurance to participate

Our promise to you

V

There will be no cost to participate in the RethinkALZ clinical trial or any study-related procedures.

V

No hospitalization is required for the study

V

You will be compensated for your time and travel for each clinical study appointment

V

A physician will always be available to discuss your results and progress

Will it cost you anything?

Absolutely free. RethinkALZ will require no cost to you and no need for insurance. You will be compensated for participating in the study.
RethinkALZ study is actively enrolling.
If you want more information about RethinkALZ or want to see if you or your loved one qualifies, call us on 844-331-7300 or fill out the form to get started now!
Please call us on 844-331-7300 or fill out the form to get started

Find out it you qualify

You can play a role in making this world a better place. Without you, new possible treatments would never be made available you or anyone else.

  • This field is for validation purposes and should be left unchanged.